SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL - News), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced today that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 10, 2007 to discuss the Company's first quarter 2007 financial results. John P. Longenecker, Ph.D., President and Chief Executive Officer of Favrille, will also present an update on the Company.
